The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Differential effects of metformin on breast cancer proliferation according to insulin resistance and tumor subtype in a presurgical trial.
Andrea De Censi
No relevant relationships to disclose
Matteo Lazzeroni
No relevant relationships to disclose
Valentina Aristarco
No relevant relationships to disclose
Matteo Puntoni
No relevant relationships to disclose
Sara Gandini
No relevant relationships to disclose
Aliana Guerrieri-Gonzaga
No relevant relationships to disclose
Harriet Ann Johansson
No relevant relationships to disclose
Massimiliano Cazzaniga
No relevant relationships to disclose
Giancarlo Pruneri
No relevant relationships to disclose
Davide Serrano
No relevant relationships to disclose
Matthias Schwab
No relevant relationships to disclose
Serena Mora
No relevant relationships to disclose
Debora Macis
No relevant relationships to disclose
Fabio Bassi
No relevant relationships to disclose
Alberto Luini
No relevant relationships to disclose
Bernardo Bonanni
No relevant relationships to disclose
Michael N. Pollak
No relevant relationships to disclose